BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wani JA, Majid S, Khan A, Arafah A, Ahmad A, Jan BL, Shah NN, Kazi M, Rehman MU. Clinico-Pathological Importance of miR-146a in Lung Cancer. Diagnostics (Basel) 2021;11:274. [PMID: 33578944 DOI: 10.3390/diagnostics11020274] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Chhetri D, Vengadassalapathy S, Venkadassalapathy S, Balachandran V, Umapathy VR, Veeraraghavan VP, Jayaraman S, Patil S, Iyaswamy A, Palaniyandi K, Gnanasampanthapandian D. Pleiotropic effects of DCLK1 in cancer and cancer stem cells. Front Mol Biosci 2022;9:965730. [DOI: 10.3389/fmolb.2022.965730] [Reference Citation Analysis]
2 Ma L, Ma L, Yang Y, Chen T, Wang L, Deng Q, Song J. Electroacupuncture-Regulated miR-34a-3p/PDCD6 Axis Promotes Post-Spinal Cord Injury Recovery in Both In Vitro and In Vivo Settings. Journal of Immunology Research 2022;2022:1-17. [DOI: 10.1155/2022/9329494] [Reference Citation Analysis]
3 Dhiflaoui A, Mahjoub S, Chayeb V, Achour B, Chouchen S, Abdennebi HB, Mahjoub T, Almawi WY. miR-146a, miR-196a2, miR-499, and miR-149 linked with susceptibility to acute lymphoblastic leukemia: A case-control study in Tunisia. Gene 2022;834:146648. [PMID: 35690283 DOI: 10.1016/j.gene.2022.146648] [Reference Citation Analysis]
4 Szczyrek M, Bitkowska P, Jutrzenka M, Milanowski J. The Role of the Selected miRNAs as Diagnostic, Predictive and Prognostic Markers in Non-Small-Cell Lung Cancer. JPM 2022;12:1227. [DOI: 10.3390/jpm12081227] [Reference Citation Analysis]
5 Wani JA, Majid S, Imtiyaz Z, Rehman MU, Alsaffar RM, Shah NN, Alshehri S, Ghoneim MM, Imam SS. MiRNAs in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Potential. Diagnostics 2022;12:1610. [DOI: 10.3390/diagnostics12071610] [Reference Citation Analysis]
6 Eshkoor SA, Ghodsian N, Akhtari-zavare M. MicroRNAs influence and longevity. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00316-7] [Reference Citation Analysis]
7 Choi SS, Kim SE, Oh SY, Ahn Y. Clinical Implications of Circulating Circular RNAs in Lung Cancer. Biomedicines 2022;10:871. [DOI: 10.3390/biomedicines10040871] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Singh V, Khurana A, Navik U, Allawadhi P, Bharani KK, Weiskirchen R. Apoptosis and Pharmacological Therapies for Targeting Thereof for Cancer Therapeutics. Sci 2022;4:15. [DOI: 10.3390/sci4020015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
9 Izzotti A, Fracchia E, Rosano C, Comite A, Belgioia L, Sciacca S, Khalid Z, Congiu M, Colarossi C, Blanco G, Santoro A, Chiara M, Pulliero A. Efficacy of High-Ozonide Oil in Prevention of Cancer Relapses Mechanisms and Clinical Evidence. Cancers 2022;14:1174. [DOI: 10.3390/cancers14051174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Vashchenko VI, Romashova JE, Shabanov PD. Pathophysiology of miR-146a in lung cancer. Prospects of rising of efficiency of targeted therapy. Rev Clin Pharm Drug Ther 2021;19:359-381. [DOI: 10.17816/rcf194359-381] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hassanein SS, Ibrahim SA, Abdel-Mawgood AL. Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands. Int J Mol Sci 2021;22:12496. [PMID: 34830377 DOI: 10.3390/ijms222212496] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]